Found 1188 matching trials
Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial
PHASE3RATIONALE: Providing information that is tailored to answer patients' quest...
Location
Barbara Ann Karmanos Cancer Institute
A Pilot Study of Autologous Ex Vivo Activated NK Cell Infusion in the Treatment of Metastatic Nasopharyngeal Carcinoma
PHASE11. To demonstrate the feasibility of leukapheresis and ex vivo activation o...
Location
National University Hospital
Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803
PHASE1The purpose of this study is to find the number of natural killer (NK) cell...
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Social Media-based Active Self-report on Incidence and Outcomes of Adverse Events in NK/TCL Patients
N/AThe purpose of this study is to collect data from patients by social media ...
Location
Lymphoma House086
Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia
PHASE1RATIONALE: Recombinant human mannose-binding lectin (MBL) may be effective ...
Location
Children's Hospital of Orange County
Natural Killer(NK) Cell Therapy in Acute Myeloid Leukemia
PHASE1This is a phase 1, first-in-human (FIH), open-label, multicohort study to e...
Location
Institute of Hematology & Blood Diseases Hospital
Gene Discovery in CHB Patients to Identify Unknown Pathways That Lead to B and NK Cell Deregulation
NANatural Killer (NK) and B cell immune responses occur during the early stag...
Location
Centre d'Investigation Clinique
Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing Cancers
PHASE1This is an open-label, multi-center study to evaluate the safety, tolerabil...
Location
USC/Norris Comprehensive Cancer Center
FT516 in Combination With Monoclonal Antibodies in Advanced Solid Tumors
PHASE1This is a Phase 1 dose-finding study of FT-516 in combination with monoclon...
Location
University of Minnesota Masonic Cancer Center
CD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation
PHASE1The investigators propose a nonrandomized, Phase I study to assess the safe...
Location
Hammersmith Hospital